Published in Healthcare Finance, Tax and Law Weekly, September 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Insmed Inc..
Report 1: Insmed Inc. (Nasdaq:INSM), (referred to herein as "Insmed", "we", "our" and "us"), a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs, announced results for the second quarter and six-month period ended June 30, 2007.
Revenues for the three months ended June 30, 2007 were $2.3 million, up from $210,000 from the corresponding...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.